Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device
SONAS
Novel Approach For The Non-Invasive Detection of Pulmonary Right-to-Left Shunts
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn how well the SONAS ultrasound device can detect right-to-left shunts of adults with hereditary hemorrhagic telangiectasia (HHT) who are already scheduled for a contrast bubble echocardiogram (TTCE). The main questions it aims to answer are:
- 1.How accurately does SONAS detect right-to-left shunts compared to the standard TTCE test?
- 2.Can SONAS results help tell the difference between shunts in the heart and shunts in the lungs?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2026
CompletedFirst Submitted
Initial submission to the registry
February 3, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFebruary 17, 2026
February 1, 2026
3 months
February 3, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Capability of detecting Right-to-Left Shunts
Device capability of detecting High Intensity Transient Signals (HITS) using SONAS in presence of RLS, as confirmed by reference method TTCE. SONAS output is expressed as maximum HITS Density Score (0-100%). TTCE outcome is assessed by RLS grade (0-3), maximum microbubble count in left ventricle, and corrected change in echo density.
Periprocedurally
Diagnostic accuracy
Diagnostic accuracy (sensitivity and specificity) of SONAS for detection of clinically significant RLS (≥grade 2 on TTCE) at different HITS Density Score thresholds.
Periprocedurally
Secondary Outcomes (2)
Distinguishing intracardiac from pulmonary Right-to-Left Shunts
Periprocedurally
Test-retest reliability of SONAS for HITS assessment
Periprocedurally
Study Arms (1)
SONAS Ultrasound During Contrast Echocardiography
EXPERIMENTALThis study has a single arm in which all participants undergo SONAS monitoring during a standard contrast echocardiogram (transthoracic contrast echocardiography). In this arm, adults with (possible) hereditary hemorrhagic telangiectasia or PFO who are already scheduled for a clinically indicated bubble echocardiogram have a headband with the SONAS ultrasound device examination. Agitated saline is injected into a vein as part of usual care, and the heart is imaged with echocardiography while SONAS simultaneously records ultrasound signals from the brain.
Interventions
The intervention is the SONAS ultrasound device used during a routine bubble echocardiogram. A battery-powered unit connects to a headset with two ultrasound sensors placed in front of the ears. The device does not deliver contrast or drugs; it records ultrasound signals in the brain while standard agitated saline is injected and the heart is imaged. SONAS analyzes bubble-related signals and calculates a numeric score to evaluate right-to-left shunts without changing the usual echocardiography protocol.
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Suspected or confirmed hereditary hemorrhagic telangiectasia (HHT).
- Incidentally: Patients who have experienced cryptogenic stroke
You may not qualify if:
- Pregnancy or breastfeeding.
- Known or suspected fracture(s) of the temporal / parietal skull bones, or with open skin injuries in the anatomical area of the temporal / parietal lobes.
- Patients with known metal skull implants in the anatomical area of the temporal / parietal bones, or with anatomical formation of the head or ear tha may interfere with proper headset placement.
- Patients with known allergies or reactions to parabens, which are present in the gel pad material of the applied part.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Antonius Hospitallead
- Burl Concepts, Inc.collaborator
Study Sites (1)
St. Antonius Hospital
Nieuwegein, Utrecht, 3435CM, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martijn C. Post, Professor
St. Antonius Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 3, 2026
First Posted
February 17, 2026
Study Start
January 7, 2026
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 3 months and ending 2 years after the publication of results.
- Access Criteria
- Fellow researchers interested in doing a meta-analysis of data will be able to access the IPD and supporting information. There will be access to the Study Protocol and anonymized individual patient data. Access is possible by contacting the Central Contact Person or Principal Investigator of the study.
All anonymized Individual Patient Data that underlie results in the publication.